Close X
Attorney Spotlight

How did an interest in healthcare policy lead Robert Platt to a career in the law? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

Envision to Sell to KKR for $9.9 Billion

We represented Envision Healthcare Corporation (NYSE: EVHC) in its definitive agreement to sell to KKR in an all-cash transaction for $9.9 billion, including debt. KKR will pay $46 per Envision share in cash to buy the company, marking a 32 percent premium to the company's volume-weighted average share price from November 1, when Envision announced it was considering its options. The transaction is expected to close the fourth quarter of 2018. Read more


Envision Healthcare

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Six Things to Know Before Buying a Physician Practice spotlight

Dermatology, ophthalmology, radiology, urology…the list goes on. Yet, in any physician practice management transaction, there are six key considerations that apply and, if not carefully managed, can derail a transaction. Download the 6 Things to Know Before Buying a Physician Practice to keep your physician practice management transactions on track.

Click here to download the guide.

James S. Tate, Jr.

Member

Nashville
(615) 742-6235 TEL
(615) 742-2735 FAX

James S. Tate, Jr.

Member

Nashville
(615) 742-6235 TEL
(615) 742-2735 FAX
Nashville
(615) 742-6235 TEL
(615) 742-2735 FAX

Jim Tate has advised clients on more than $13 billion in corporate financing, commercial lending and real estate transactions in the last three years alone. Focusing his practice primarily on representing borrowers in large syndicated bank credit facilities, Jim also represents banks and other lenders in lending transactions and handles a variety of real estate projects.

Jim's practice involves:

  • Commercial Finance – Representing borrowers in large corporate financings, including syndicated senior revolving credit and term loan facilities (secured and unsecured), sale/leasebacks and other specialized financings; and representing agent banks and lenders in revolving credit and term loan facilities for both public and private companies in a variety of industries, with a special emphasis on healthcare and healthcare-related companies.
  • Real Estate – Representing developers and other real estate clients in connection with a variety of real estate acquisitions, dispositions, commercial leasing and development projects.

A private pilot, Jim enjoys addressing aviation-related matters for clients, including the sale, purchase and financing of aircraft. Jim is also actively involved in the firm's legal opinion practice, primarily with respect to matters of Tennessee law in multi-state financing transactions.

Memberships

American Health Lawyers Association (AHLA)

News

View More

Representative Experience

View More

Media Mentions

View More

Accolades

Chambers USA Banking & Finance (2008-2018); Real Estate (2005-2006)

Best Lawyers in America® — Nashville Securitization and Structured Finance Law "Lawyer of the Year" (2016); Nashville Commercial Finance Law "Lawyer of the Year" (2015); Nashville Banking and Finance Law "Lawyer of the Year" (2010)

Best Lawyers in America® — Banking and Finance Law; Commercial Finance Law; Commercial Transactions/UCC Law; Real Estate Law; Securitization and Structured Finance Law (1995-2018)

Mid-South Super Lawyers (2006-2013)

Nashville Business Journal "Best of the Bar" (2011-2012)

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.